Navigation Links
IAEA and NFCR join forces to fight cancer in developing world
Date:10/25/2007

IAEA Director General and Nobel Laureate Mohamed ElBaradei will join more than 100 leading public figures, philanthropists and cancer experts at the United Nations Headquarters in New York on 29 October to mark the launch of a new partnership between the IAEA and the US based National Foundation for Cancer Research (NFCR). Through this partnership, and the endowment fund called the PACT Fund at NFCR, Americans can support the IAEA and its partners in helping poor countries to combat the looming cancer epidemic.

"The IAEA has long provided radiotherapy machines and expertise to developing countries, but the growing cancer crisis cannot be fought with radiotherapy alone," says Mohamed ElBaradei. "Our Programme of Action for Cancer Therapy (PACT), which draws on the Agencys long experience in radiation therapy, is building international partnerships to assist in cancer prevention, early detection, treatment and palliative care. Now, through the PACT Fund at NFCR, Americans have the opportunity to support these efforts and bring hope to millions of cancer patients in developing nations."

According to the World Health Organization (WHO), the world is on the brink of a cancer crisis. New cases are expected to double to more than 16 million a year by 2020, unless action is taken now. Hardest hit will be low-income countries, whose health systems are already overburdened by infectious diseases such as HIV/AIDS, Tuberculosis and Malaria.

PACT, which was created within the IAEA in 2004, is forging international partnerships with other cancer organizations in both the public and private sectors. Together with partners such as WHO, the American Cancer Society (ACS) and the National Cancer Institute (NCI), it has established pilot projects called Model Demonstration Sites (PMDS) in six countries (Albania, Nicaragua, Sri Lanka, Tanzania, Vietnam and Yemen) to develop and implement comprehensive, integrated cancer control programmes crafted to meet the specific needs of each country.

"PACT and its partners are working closely together to help low-income countries expand their cancer control and care capacities in a sustainable manner," says Massoud Samiei, Head of the PACT Programme Office. "Our priority through these pilot projects is to demonstrate that cancer is a preventable and a curable disease. If sufficient funds were available millions of lives could be saved, even with relatively simple solutions."

PACT estimates that the implementation of all six PMDS projects will total some $28 million. The launch of the PACT Fund at NFCR will enable Americans to donate to the efforts of PACT and its partners in Africa, Asia and Latin America to meet the challenge, and thus contribute to placing cancer on the global health agenda.

Founded in 1973, NFCR is internationally recognized for its leadership in cancer research and public education relating to all aspects of cancer care and control. Based in Bethesda, Maryland, NFCR is committed to innovative research and accelerating the pace at which new treatment and therapies are brought to patients who need them the most.

"Millions of lives needlessly are lost to cancer in developing countries because effective therapies all too often are not available," says Franklin C. Salisbury, Jr., President and CEO of NFCR. "We are committed to ending this tragic loss. We will make the PACT Fund at NFCR a stronghold in the fight against cancer in developing countries."


'/>"/>

Contact: Angela Leuker
A.Leuker@iaea.org
0043-126-002-2627
International Atomic Energy Agency
Source:Eurekalert

Related medicine news :

1. Mechanical forces drive early heart development
2. A Joint Venture by Golfers And Military Forces To Combat AIDS
3. Lunar Forces Affect The Surface Of The Earth
4. Shortage of services forces delayed hospital treatment for patient.
5. Patient Safety Forces Closure Of Hospital
6. Massive Culling Of Poultry Forces Farm Owner To Commit Suicide
7. Pakistan Enforces Strict Bird Flu Measures, Poultry Import Banned
8. New Government Contract Forces Dentists To Quit The NHS
9. Incidence Of HIV/AIDS In The Indian Armed Forces Negligible
10. High Cost Forces NHS To Reject Inhaled Insulin
11. Malaria Epidemic Forces Assam Rebels Out Of The Jungle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... ... therapy products, announced today the introduction of the newly designed, innovative shoulder wrap. ... and better cold therapy coverage for the injured arm and shoulder to promote ...
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... i2i Systems, ... of the highest preliminary data vendors in the latest KLAS report, Population Health Management ... has led the developing market for population health management (PHM). The latest KLAS ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Federal Laboratory ... federallabs.org . The site houses a wealth of federal resources that businesses can ... process called technology transfer (T2). As a network of over 300 federal laboratories, ...
(Date:2/8/2016)... , ... February 08, 2016 , ... The Valentine’s Season is famous for gift giving ... significant others that they are loved. This year, for more than 5.6 million Americans ... - just won't be enough to remind them of the lives they’ve led and the ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... and clothing, announced expansion into Canada to provide its range of unique and ... sales office in Quebec City that will provide bilingual customer service and marketing ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... 2016  The Parenteral Drug Association, Inc. (PDA), ... manufacturing sterile drug products, today announced the publication ... – With link to Comparison Spreadsheet. The ... U.S. FDA, the EU, the Pharmaceutical Inspection Convention/Scheme ... --> --> PDA,s Global Sterile ...
(Date:2/8/2016)... LONDON , Feb.8, 2016 Cardiovascular ... Summary GlobalData,s Medical Devices sector report, ... 2015" provides an overview of Cardiovascular Surgery Devices ... --> The report provides comprehensive ... of the products at various stages of development. ...
(Date:2/8/2016)... and FAIRFIELD, N.J. , Feb. 8, ... Pharmaceuticals, Inc. (Medimetriks) today announced that they have entered ... commercialization rights for OPA-15406 in the U.S. and ... manufacturing rights.  OPA-15406 is a topical, non-steroidal phosphodiesterase IV ... --> --> In ...
Breaking Medicine Technology: